Cite

HARVARD Citation

    Amitai, I. et al. (2021). Patient‐reported fatigue refines prognosis in higher‐risk myelodysplastic syndromes (MDS): a MDS‐CAN study. British journal of haematology. pp. 319-324. [Online]. 
  
Back to record